Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI we wish to inform you that the Board of Directors (the Board) of ADS Diagnostic Limited (the Company) at its meeting held today i.e. Friday 13th February 2026 considered and approved the Unaudited Standalone Financial Results of the Company for the quarter Ended 31st December 2025.